Cargando…
Preventative Effect of Mebendazole against Malignancies in Neurofibromatosis 1
Patients with RASopathy Neurofibromatosis 1 (NF1) are at a markedly increased risk of the development of benign and malignant tumors. Malignant tumors are often recalcitrant to treatments and associated with poor survival; however, no chemopreventative strategies currently exist. We thus evaluated t...
Autores principales: | Staedtke, Verena, Gray-Bethke, Tyler, Riggins, Gregory J., Bai, Ren-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397152/ https://www.ncbi.nlm.nih.gov/pubmed/32650362 http://dx.doi.org/10.3390/genes11070762 |
Ejemplares similares
-
Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model
por: Williamson, Tara, et al.
Publicado: (2016) -
Neutrophil depletion enhanced the Clostridium novyi-NT therapy in mouse and rabbit tumor models
por: Staedtke, Verena, et al.
Publicado: (2021) -
Prevention of tumor seeding during needle biopsy by chemotherapeutic-releasing gelatin sticks
por: Bai, Ren-Yuan, et al.
Publicado: (2017) -
Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial
por: Gallia, Gary L, et al.
Publicado: (2020) -
Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness
por: Joe, Natalie S., et al.
Publicado: (2022)